Common Malignancies / Oncology
General Medicine · Topic 13
Source: NMC CBME Curriculum 2024 · Volume II · General Medicine · Topic 13 · combined PDF page 302
Practice questions
- A review describes several routes by which the gut microbiome may influence gastrointestinal carcinogenesis. Which set most closely matches the mechanisms summarized?
- A clinician sees a report associating a microbial taxon with colorectal cancer and concludes that the organism is proven to cause the cancer. Which interpretation best reflects the evidence framework in the review?
- Which organism–cancer relationship is specifically named in the review as part of the tumor-specific microbiome discussion?
- A research team proposes fecal microbiota transplantation as a cancer-directed intervention. Which statement is most consistent with the review's appraisal?
- Which approach is identified as a potential means of advancing microbiome-based precision oncology?
- Which group contains only hepatic malignancy settings for which the review describes liver transplantation as being offered to selected patients?
- A patient has colorectal cancer with liver metastases. Which feature most closely matches the metastatic setting for which the review describes transplantation in selected patients?
- What is the central qualification attached to the review's discussion of liver transplantation for hepatic malignancies?
- According to the review, what has helped some previously transplant-ineligible patients be considered for curative-intent transplantation?
- A colorectal cancer team argues that tumor location alone must determine treatment. Which principle from the precision-oncology review most directly challenges this statement?
- Which group of cancers is within the scope of the precision-oncology review?
- A new assay is described as cutting-edge and is undergoing active research. What conclusion is justified by the review?
- Which statement best summarizes the evidence-based goal of precision oncology described in the review?
- Which set of thoracic oncology topics is specifically identified as having advanced in the Journal of Thoracic Oncology's history?
- What is the clinical relevance attributed to pathology, molecular genetics, and biomarker testing in the thoracic oncology review?
- In the review's account of the journal's 20-year history, how many of its top 20 most-cited articles were led by pathologists?
- A child with cancer is receiving curative-intent treatment but has substantial physical and emotional burdens. Which approach is consistent with the pediatric palliative surgical oncology review?
- Which statement about survival and burden in pediatric cancer best reflects the supplied review?
- In the prospective single-arm study of touch care with aromatherapy in hospitalized patients with thoracic malignancies, which result was reported among the evaluable participants?
- A hospital introduces a slow paclitaxel infusion protocol specifically to reduce hypersensitivity reactions. In the cited pre/post study, what happened to the overall reaction rate?
- In the paclitaxel infusion study, which outcomes did not differ between the pre- and post-intervention cohorts?
- Which conclusion best accounts for both the paclitaxel study result and its design?
- Which historical contribution is described in the review of Japanese orthopedic oncology?
- Which option lists only examples of recycled treated autograft methods described in the orthopedic oncology review?
- In the orthopedic oncology review, what does the phrase “Cancer Locomo” refer to?
- Which statement best explains why registry and collaborative research infrastructure is emphasized in the history of orthopedic oncology?
- A patient with cancer has physical symptoms and emotional distress while receiving active treatment. Which statement best reflects the role of palliative care in the supplied oncology literature?
- Which inference is most appropriate from the reported pre- and post-session improvements in some subjective measures in the touch-care and aromatherapy study?
- Which group of organizations is identified as part of the collaborative infrastructure for Japanese orthopedic oncology?